| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.21 | 4e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.16 | 0.0003 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.15 | 0.0007 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |